{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:34:19Z","timestamp":1791232459262,"version":"4.1.0"},"reference-count":30,"publisher":"Japan Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1507\/endocrj.ej24-0093","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T22:11:16Z","timestamp":1724710276000},"page":"1165-1173","source":"Crossref","is-referenced-by-count":6,"title":["A case of central diabetes insipidus after COVID-19 as a probable diagnosis of lymphocytic infundibulo-neurohypophysitis with positive anti-rabphilin-3A antibodies with review of literature"],"prefix":"10.1507","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0050-7595","authenticated-orcid":false,"given":"Yuka","family":"Natsuki","sequence":"first","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9519-3332","authenticated-orcid":false,"given":"Yuki","family":"Nagata","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan"},{"name":"Vascular Science Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Nagasaki","sequence":"additional","affiliation":[{"name":"Nagasaki Thyroid Clinic, Osaka 546-0014, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norikazu","family":"Toi","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2571-9375","authenticated-orcid":false,"given":"Masafumi","family":"Kurajoh","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2329-8191","authenticated-orcid":false,"given":"Tomoaki","family":"Morioka","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3953-0925","authenticated-orcid":false,"given":"Tetsuo","family":"Shoji","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan"},{"name":"Vascular Science Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9077-2631","authenticated-orcid":false,"given":"Yasuo","family":"Imanishi","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2151-0966","authenticated-orcid":false,"given":"Naoko","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, Fujita Health University School of Medicine, Aichi 470-1192, Japan"},{"name":"Department of Endocrinology and Diabetes, Daido Hospital, Aichi 457-0818, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2941-9968","authenticated-orcid":false,"given":"Haruki","family":"Fujisawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, Fujita Health University School of Medicine, Aichi 470-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0807-199X","authenticated-orcid":false,"given":"Atsushi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, Fujita Health University School of Medicine, Aichi 470-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8702-2283","authenticated-orcid":false,"given":"Yoshihisa","family":"Sugimura","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, Fujita Health University School of Medicine, Aichi 470-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Emoto","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan"},{"name":"Vascular Science Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1 Han Q, Zheng B, Daines L, Sheikh A (2022) Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens 11: 269.","DOI":"10.3390\/pathogens11020269"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2 Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, et al. (2023) Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA 329: 1934\u20131946.","DOI":"10.1001\/jama.2023.8823"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Das L, Dutta P, Walia R, Mukherjee S, Suri V, et al. (2021) Spectrum of endocrine dysfunction and association with disease severity in patients with COVID-19: insights from a cross-sectional, observational study. Front Endocrinol (Lausanne) 12: 645787.","DOI":"10.3389\/fendo.2021.645787"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Marazuela M, Giustina A, Puig-Domingo M (2020) Endocrine and metabolic aspects of the COVID-19 pandemic. Rev Endocr Metab Disord 21: 495\u2013507.","DOI":"10.1007\/s11154-020-09569-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Partenope C, Pedranzini Q, Petri A, Rabbone I, Prodam F, et al. (2023) AVP deficiency (central diabetes insipidus) following immunization with anti-COVID-19 BNT162b2 comirnaty vaccine in adolescents: a case report. Front Endocrinol (Lausanne) 14: 1166953.","DOI":"10.3389\/fendo.2023.1166953"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Matsuo T, Okubo K, Mifune H, Imao T (2023) Bilateral optic neuritis and hypophysitis with diabetes insipidus 1 month after COVID-19 mRNA vaccine: case report and literature review. J Investig Med High Impact Case Rep 11: 23247096231186046.","DOI":"10.1177\/23247096231186046"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Iwama S, Sugimura Y, Kiyota A, Kato T, Enomoto A, et al. (2015) Rabphilin-3A as a targeted autoantigen in lymphocytic infundibulo-neurohypophysitis. J Clin Endocrinol Metab 100: E946\u2013E954.","DOI":"10.1210\/jc.2014-4209"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Kume Y, Sakuma H, Sekine H, Sumikoshi M, Sugimura Y, et al. (2021) Lymphocytic infundibuloneurohypophysitis with positive anti-rabphilin-3A antibodies nine years post-onset of central diabetes insipidus. Clin Pediatr Endocrinol 30: 65\u201369.","DOI":"10.1297\/cpe.30.65"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Arihara Z, Sakurai K, Niitsuma S, Sato R, Yamada S, et al. (2022) Studies on anti-rabphilin-3A antibodies in 15 consecutive patients presenting with central diabetes insipidus at a single referral center. Sci Rep 12: 4440.","DOI":"10.1038\/s41598-022-08552-y"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Takagi H, Iwama S, Sugimura Y, Takahashi Y, Oki Y, et al. (2020) Diagnosis and treatment of autoimmune and IgG4-related hypophysitis: clinical guidelines of the Japan Endocrine Society. Endocr J 67: 373\u2013378.","DOI":"10.1507\/endocrj.EJ19-0569"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Yasuda Y, Iwama S, Kiyota A, Izumida H, Nakashima K, et al. (2018) Critical role of rabphilin-3A in the pathophysiology of experimental lymphocytic neurohypophysitis. J Pathol 244: 469\u2013478.","DOI":"10.1002\/path.5046"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Rajevac H, Bachan M, Khan Z (2020) Diabetes insipidus as a symptom of Covid-19 infection: case report. Chest 158: A2576.","DOI":"10.1016\/j.chest.2020.09.172"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Sheikh AB, Javed N, Sheikh AAE, Upadhyay S, Shekhar R (2021) Diabetes insipidus and concomitant myocarditis: a late sequelae of COVID-19 infection. J Investig Med High Impact Case Rep 9: 2324709621999954.","DOI":"10.1177\/2324709621999954"},{"key":"14","unstructured":"14 Sheikh AB, Javaid MA, Sheikh AAE, Shekhar R (2021) Central adrenal insufficiency and diabetes insipidus as potential endocrine manifestations of COVID-19 infection: a case report. Pan Afr Med J 38: 222."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Misgar RA, Rasool A, Wani AI, Bashir MI (2021) Central diabetes insipidus (Infundibuloneuro hypophysitis): a late complication of COVID-19 infection. J Endocrinol Invest 44: 2855\u20132856.","DOI":"10.1007\/s40618-021-01627-z"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Yavari A, Sharifan Z, Larijani B, Mosadegh Khah A (2022) Central diabetes insipidus secondary to COVID-19 infection: a case report. BMC Endocr Disord 22: 134.","DOI":"10.1186\/s12902-022-01048-w"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17 Ach T, Kammoun F, Fekih HE, Slama NBH, Kahloun S, et al. (2023) Central diabetes insipidus revealing a hypophysitis induced by SARS-CoV-2 vaccine. Therapie 78: 453\u2013455.","DOI":"10.1016\/j.therap.2022.09.007"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Ankireddypalli AR, Chow LS, Radulescu A, Kawakami Y, Araki T (2022) A case of hypophysitis associated with SARS-CoV-2 vaccination. AACE Clin Case Rep 8: 204\u2013209.","DOI":"10.1016\/j.aace.2022.06.001"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Lizzi M, Arico M, Carlone G, Anzellotti MT, Trotta D, et al. (2022) Central diabetes insipidus: another rare complication of SARS-CoV-2 infection in children? Pediatr Infect Dis J 41: e448.","DOI":"10.1097\/INF.0000000000003632"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Bouca B, Roldao M, Bogalho P, Cerqueira L, Silva-Nunes J (2022) Central diabetes insipidus following immunization with BNT162b2 mRNA COVID-19 vaccine: a case report. Front Endocrinol (Lausanne) 13: 889074.","DOI":"10.3389\/fendo.2022.889074"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Suresh Kumar S, Kumar K, Venkataramani S, Ghazi NM (2023) Central diabetes insipidus: an acute manifestation of COVID-19 infection. Cureus 15: e43884.","DOI":"10.7759\/cureus.43884"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Ishay A, Shacham EC (2023) Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine? BMC Endocr Disord 23: 47.","DOI":"10.1186\/s12902-023-01296-4"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, et al. (2005) Autoimmune hypophysitis. Endocr Rev 26: 599\u2013614.","DOI":"10.1210\/er.2004-0011"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Chiloiro S, Capoluongo ED, Tartaglione T, Giampietro A, Bianchi A, et al. (2019) The changing clinical spectrum of hypophysitis. Trends Endocrinol Metab 30: 590\u2013602.","DOI":"10.1016\/j.tem.2019.06.004"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Leow MK, Kwek DS, Ng AW, Ong KC, Kaw GJ, et al. (2005) Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol (Oxf) 63: 197\u2013202.","DOI":"10.1111\/j.1365-2265.2005.02325.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Lazartigues E, Qadir MMF, Mauvais-Jarvis F (2020) Endocrine significance of SARS-CoV-2\u2019s reliance on ACE2. Endocrinology 161: bqaa108.","DOI":"10.1210\/endocr\/bqaa108"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Chigr F, Merzouki M, Najimi M (2020) Autonomic brain centers and pathophysiology of COVID-19. ACS Chem Neurosci 11: 1520\u20131522.","DOI":"10.1021\/acschemneuro.0c00265"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Pal R, Banerjee M (2020) COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest 43: 1027\u20131031.","DOI":"10.1007\/s40618-020-01276-8"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 de Melo IS, Sabino-Silva R, Cunha TM, Goulart LR, Reis WL, et al. (2021) Hydroelectrolytic disorder in COVID-19 patients: evidence supporting the involvement of subfornical organ and paraventricular nucleus of the hypothalamus. Neurosci Biobehav Rev 124: 216\u2013223.","DOI":"10.1016\/j.neubiorev.2021.02.008"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Iadecola C, Anrather J, Kamel H (2020) Effects of COVID-19 on the nervous system. Cell 183: 16\u201327.e1.","DOI":"10.1016\/j.cell.2020.08.028"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/71\/12\/71_EJ24-0093\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T03:33:50Z","timestamp":1733542430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/71\/12\/71_EJ24-0093\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0093","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"EJ24-0093"}}